Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study

Autor: Freyer, Gilles, Martinez-Jañez, Noelia, Kukielka-Budny, Bożena, Ulanska, Malgorzata, Bourgeois, Hugues, Muñoz, Montserrat, Morales, Serafin, Calero, Juan Bayo, Cortesi, Laura, Pintér, Tamás, Palácová, Markéta, Cherciu, Nelli, Petru, Edgar, Ettl, Johannes, de Almeida, Cécilia, Villanova, Gustavo, Raymond, Romain, Minh, Christine Ta Thanh, Rodrigues, Ana, Cazzaniga, Marina E.
Zdroj: In The Breast April 2024 74
Databáze: ScienceDirect
Externí odkaz: